Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot B Levy

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Hepatology Communications|August 11, 2018
Spleen and Liver Volumetrics as Surrogate Markers of Hepatic Venous Pressure Gradient in Patients With Noncirrhotic Portal HypertensionOhad Etzion, Varun Takyar, Victor Novack, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 12, 2017
Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™Koorosh Ashrafi, Yiqing Tang, Hugh Britton, et al.
Cancer Letters|August 11, 2025
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancersChi Ma, Joy A Awosika, Cecilia Monge, et al.
Journal for Immunotherapy of Cancer|February 8, 2023
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancerCecilia Monge, Changqing Xie, Yuta Myojin, et al.
Journal of Clinical and Translational Hepatology|April 13, 2026
Association of Changes in Portal Insulin with Immunometabolism During and After Hepatitis C Virus InfectionMatthew G Menkart, Jenna L Oringher, Moumita Chakraborty, et al.
Nature Microbiology|December 15, 2022
Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosisRabab O Ali, Gabriella M Quinn, Regina Umarova, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Hepatology Communications|August 11, 2018
Spleen and Liver Volumetrics as Surrogate Markers of Hepatic Venous Pressure Gradient in Patients With Noncirrhotic Portal HypertensionOhad Etzion, Varun Takyar, Victor Novack, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 12, 2017
Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™Koorosh Ashrafi, Yiqing Tang, Hugh Britton, et al.
Cancer Letters|August 11, 2025
Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancersChi Ma, Joy A Awosika, Cecilia Monge, et al.
Journal for Immunotherapy of Cancer|February 8, 2023
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancerCecilia Monge, Changqing Xie, Yuta Myojin, et al.
Journal of Clinical and Translational Hepatology|April 13, 2026
Association of Changes in Portal Insulin with Immunometabolism During and After Hepatitis C Virus InfectionMatthew G Menkart, Jenna L Oringher, Moumita Chakraborty, et al.
Nature Microbiology|December 15, 2022
Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosisRabab O Ali, Gabriella M Quinn, Regina Umarova, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Pageof 4